GLP‑1 Atlas

Hair shedding on a GLP-1

Common, alarming, and usually not the drug. What telogen effluvium is, why rapid weight loss triggers it, and what actually helps.

The short version

  • Shedding typically starts two to four months after rapid weight loss begins — not when the medicine starts.
  • The likely mechanism is telogen effluvium: a stress response to rapid loss and reduced intake, not a direct drug effect.
  • It is usually temporary. Hair follicles are not destroyed; their cycle is interrupted.
  • Protein, iron, and losing weight at a moderate pace are the levers that exist.

This is one of the most distressing things people encounter on this treatment and one of the least well explained. The pattern is consistent enough to be reassuring once you understand it: it arrives late, it is diffuse rather than patchy, and it stops.

What telogen effluvium is

Hair grows in cycles. At any time most of your follicles are in an active growing phase, and a minority are in a resting phase that ends with the hair being shed and replaced.

A significant physiological stress can push an unusually large number of follicles into that resting phase at once. Because the resting phase lasts around two to three months, the shedding does not appear immediately — it appears months later, when all of those follicles release their hairs together. That is telogen effluvium, and rapid weight loss is a well-established trigger.

The delay is why people connect it to the wrong cause. The shedding in month four traces back to the stress in month two — by which point the treatment has become routine and nothing seems to have changed.

Why weight loss triggers it

Several things arrive at once, and hair is a low-priority tissue when resources are limited.

  • Reduced protein intake. Hair is largely protein. When intake falls, follicles are among the first structures deprioritised.
  • Reduced micronutrient intake. Iron in particular, and also zinc, B12 and vitamin D. Eating a third less of everything means less of all of them.
  • The energy deficit itself, independent of any specific nutrient.
  • The pace. Faster loss is a larger stress. This is one more reason moderate loss beats rapid loss.

None of these is specific to GLP-1 medicines. The same pattern appears after bariatric surgery, after crash dieting, after childbirth and after serious illness — all situations that share rapid change rather than a particular drug.

What it looks like

  • Diffuse, not patchy. Thinning across the whole scalp rather than defined bald areas.
  • More hair in the brush, the shower drain, on the pillow.
  • A smaller ponytail rather than visible bald patches.
  • Starting two to four months in and typically continuing for a few months before settling.

Patchy loss is a different thing. Defined circular bald patches, loss confined to one area, or scalp that is itchy, scaly or painful are not telogen effluvium and warrant seeing a clinician. So does shedding that continues beyond six months without improving.

What actually helps

Protein, again

The most direct lever, and the one already at the centre of this treatment for entirely separate reasons. Hair is made of protein; a body short of it does not spend it on hair. The targets are here.

Check iron rather than guessing

Low ferritin is a well-established contributor to hair shedding and is common in people eating substantially less — particularly in menstruating women. This is worth a blood test rather than a supplement bought on suspicion. Iron supplementation when you are not deficient is not harmless.

Slow the pace if you can

Rate of loss is a modifiable input. If shedding is severe and your loss has been very fast, that is a legitimate thing to raise with your prescriber — it is one of several reasons a slower descent is generally better.

Be gentle with what you have

Not a treatment, but it reduces breakage on top of shedding: less heat, less tension from tight styles, a wide-toothed comb, and less frequent aggressive brushing.

What does not help

  • Most hair supplements. Products marketed for hair growth are largely unevidenced, and biotin in particular — the most common ingredient — is rarely deficient and can interfere with several laboratory tests, including thyroid and cardiac assays.
  • Stopping the medicine impulsively. The shedding is driven by rapid loss rather than the drug, and it resolves on its own. Stopping abruptly trades a temporary problem for a permanent one.
  • Panicking about the timeline. Because of the delay in the hair cycle, shedding often peaks around the time the trigger has already passed.

When it stops

Telogen effluvium is self-limiting. Once the trigger settles — weight loss slows, intake stabilises, deficiencies are corrected — the follicles re-enter their growing phase, and shedding stops over a few months. Regrowth follows, though it takes longer to be visible than the shedding took to appear, because hair grows about a centimetre a month.

Most people find that by the time they have stopped worrying about it, it has already resolved. That is genuinely how it usually goes, and it is worth knowing in advance rather than discovering afterwards.

What to expect from regrowth

Hair grows roughly a centimetre a month, which means regrowth is slow to become visible even once shedding has stopped. The first sign is usually short new hairs at the hairline and parting rather than any change in overall density.

Expect three to six months before the shedding settles and a further several months before thickness visibly returns. That timeline is frustrating and it is also the normal one — it is not evidence that something further is wrong.

Sources

  1. Clinical literature on telogen effluvium, including rapid weight loss and nutritional deficiency as triggers.
  2. Guidance on iron deficiency and hair loss assessment.
  3. Reports on biotin interference with immunoassay laboratory testing.

Related

Which medicine you are on

Everything above applies across the class, because it comes from a shared mechanism. The numbers that differ — dose ladders, missed-dose windows, in-use storage periods, half-lives — differ by product, sometimes substantially. Each medicine has its own reference here:

Ozempic · Wegovy · Mounjaro · Zepbound · Rybelsus · Saxenda · Victoza · Trulicity · all medicines

How this page is sourced. Figures come from manufacturers' approved labelling and from published clinical and pharmacokinetic literature. Regional labels differ, sometimes materially — where a number matters, the leaflet in your own box outranks anything written here. This site is not written or medically reviewed by clinicians, and we say so rather than implying otherwise; our editorial standards set out what that means and how corrections work.